La Fondation du Souffle, reconnue d’Utilité Publique, agit pour le Souffle et pour la Vie. Nous finançons la Recherche, aidons les malades, développons la prévention et l'éducation.
- Testez votre souffle
Connaître sa santé respiratoire
Questionnaire en ligne gratuit
- Maladies Respiratoires
Donnez, Cherchons, Respirez
Votre soutien est crucial
- Faites un don en ligne
Soutenez la Fondation du Souffle
La Recherche a besoin de vous
- Nous soutenir
Don ponctuel, Cagnotte en ligne
Legs, Don régulier, bénévolat
- Testez votre souffle
Résultats de recherche
Il y a 3 heures · The US Food and Drug Administration announced Friday that it had advised the makers of the Covid-19 vaccines to formulate their new shots to be a better match for the JN.1 lineage of the coronavirus.
Il y a 7 heures · June 7, 2024 3:00 PM EDT. T aking the COVID-19 antiviral Paxlovid does not appear to improve Long COVID symptoms in a meaningful way, a new study finds. Those results are a blow to the millions of ...
Il y a 1 jour · La Food and Drug Administration (FDA) des États-Unis a informé vendredi les fabricants du vaccin COVID-19 que les nouvelles injections pour la campagne de l'automne 2024 devraient cibler la ...
Il y a 1 jour · Scientists and patients had hoped that Pfizer's two-drug oral treatment would ease symptoms of long COVID after anecdotal reports of patients who said Paxlovid helped them. But the 15-week, 155 ...
Il y a 7 heures · A 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long COVID, according a study by Stanford University researchers. Currently, there are no proven ...
Il y a 2 heures · Background To report a case of Multiple Evanescent White Dot Syndrome (MEWDS) one month after a COVID-19 infection in a female patient at an age unusual for the occurrence of this disease. Case presentation A 69-year-old Caucasian female reported the presence of floaters, photopsia, and enlarging vision loss in her left eye following the COVID-19 infection. Clinical and multimodal imaging was ...
Il y a 1 jour · FRIDAY, June 7, 2024 (HealthDay News) -- An extended course of the antiviral drug Paxlovid won’t ease a person’s Long COVID symptoms, a new study finds. People who took Paxlovid for 15 days -- three times as long as it’s prescribed for an initial COVID infection -- had no better improvement in their Long COVID than people taking a placebo ...
